Daniel H. Park

Low dose methotrexate enhances lymphocytic JAM-A expression in rheumatoid arthritis

Objectives Endothelial Junction Adhesion Molecule A (JAM-A) functionally manages immune cell infiltration via tight junctions during the pathological development of human immune diseases. However, the expression and function of JAM-A on peripheral lymphocytes are yet to be well u...